MLYS Earning Date, Earning Analysis and Earning Prediction

Quarterly Results

MLYS Earnings Forecast

RevenueEPS

Currency: USD

Revenue Estimate-:0

EPS Estimate-:0

—

Stock Price0

Stock Price

Go Down

-24.88%

In Past 3 Month

Earnings Forecast

Revenue

EPS

Currency:

No data

Actual

Estimate

AI Analysis

Earnings Surprise Analysis

Revenue

EPS

AI Analysis

Earnings Reaction

The chart below shows how MLYS performed 10 days before and after its earnings report, based on data from the past quarters. Typically, MLYS sees a -1.58% change in stock price 10 days leading up to the earnings, and a -5.60% change 10 days following the report. On the earnings day itself, the stock moves by +3.97%. This data can give you a slight idea of what to expect for the next quarter's release.

For example, in SEP/2025, the stock changed 5.87% on the day following the earnings release and then changed by -4.27% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.

People Also Watch

Frequently Asked Questions

What were the key highlights of MLYS's latest earnings report for FY2025Q3?

MLYS reported its FY2025Q3 earnings on 2025-11-10, showcasing a revenue of 0.00 against an estimate of 37.00M, resulting in a -100% surprise. The EPS was -0.52, surpassing the expected -0.66 by 21.21% . The stock experienced a 5.87% price change on the earnings day and a -8.2% change over the next five days, reflecting market reactions to the results.

How did MLYS's stock price react after the FY2025Q3 earnings release?

Following MLYS's FY2025Q3 earnings announcement on 2025-11-10, the stock price moved by 5.87% on the day of the release. Over the subsequent five days, it saw a -8.20% change. Historically, MLYS's stock price tends to shift by an average of -1.58% in the 10 days leading up to earnings and -5.60% in the 10 days following, providing insight into potential market.

What are the revenue and EPS estimates for MLYS for undefined?

For , analysts estimate MLYS’s annual revenue to reach undefined, while the EPS is projected at -1.00. These estimates reflect recent revisions, with revenue estimates revised Revenue Go Down by -24.88% and EPS estimates No Change by % over the past three months, indicating analyst expectation in the company’s performance.

How does MLYS's stock price correlate with earnings forecast revisions?

The correlation between MLYS's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for were Go Down by -24.88%, while EPS estimates moved No Change by % . This trend suggests that price dips could present buying opportunities for investors.

What should investors expect from MLYS's next earnings report?

Based on historical trends, MLYS's stock price typically moves by -1.58% in the 10 days before its earnings and -5.60% in the 10 days after. For the upcoming earnings, analysts expect an EPS of -1.00 and revenue of undefined.

What is the sentiment in Mineralys Therapeutics Inc (MLYS) Q3 2025 Earnings Call Summary?

The earnings call shows mixed signals: a decrease in net loss and strong intent from healthcare professionals to prescribe lorundrostat are positive, but increased expenses and management's avoidance of specifics during the Q&A raise concerns. The company's confidence in their product and ongoing trials suggests stability, while lack of detailed guidance and partnership updates tempers optimism. These factors balance each other out, leading to a neutral sentiment rating.